Does CLONAZEPAM Cause Hepatic lesion? 29 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Hepatic lesion have been filed in association with CLONAZEPAM (Clonazepam). This represents 0.1% of all adverse event reports for CLONAZEPAM.
29
Reports of Hepatic lesion with CLONAZEPAM
0.1%
of all CLONAZEPAM reports
0
Deaths
24
Hospitalizations
How Dangerous Is Hepatic lesion From CLONAZEPAM?
Of the 29 reports, 24 (82.8%) required hospitalization.
Is Hepatic lesion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLONAZEPAM. However, 29 reports have been filed with the FAERS database.
What Other Side Effects Does CLONAZEPAM Cause?
Drug ineffective (5,088)
Toxicity to various agents (4,028)
Completed suicide (3,320)
Drug abuse (3,287)
Off label use (2,590)
Anxiety (2,376)
Somnolence (2,260)
Dyspnoea (1,987)
Depression (1,838)
Insomnia (1,836)
What Other Drugs Cause Hepatic lesion?
OCTREOTIDE (296)
EVEROLIMUS (171)
RIBOCICLIB (144)
LETROZOLE (139)
CAPECITABINE (124)
ADALIMUMAB (123)
METHOTREXATE (108)
FULVESTRANT (107)
PALBOCICLIB (104)
CYCLOPHOSPHAMIDE (101)
Which CLONAZEPAM Alternatives Have Lower Hepatic lesion Risk?
CLONAZEPAM vs CLONIDINE
CLONAZEPAM vs CLOPIDOGREL
CLONAZEPAM vs CLOPIDOGREL BESILATE
CLONAZEPAM vs CLOPIDOGREL BISULFATE
CLONAZEPAM vs CLORAZEPATE